Ixabepilone companion diagnostic - Allarity Therapeutics
Alternative Names: Ixabepilone DRP®; Ixabepilone DRP®companion diagnosticLatest Information Update: 02 Oct 2021
At a glance
- Originator Allarity Therapeutics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Breast cancer